Home Physical Sciences Chapter 9 Recent advances in mesoporous silica nanoparticles research
Chapter
Licensed
Unlicensed Requires Authentication

Chapter 9 Recent advances in mesoporous silica nanoparticles research

  • Bhushan R. Rane , Vaibhav L. Patil , Nandini R. Mhatre , Aditi P. Padave , Nikita P. Mane , Mayur R. Gavit , Sachin N. Kothawade and Ashish S. Jain
Become an author with De Gruyter Brill
Mesoporous Silica Nanoparticles
This chapter is in the book Mesoporous Silica Nanoparticles

Abstract

Mesoporous silica materials came to light in the early 1990s when a new class of molecular sieves known as M41S was discovered. Greater surface area, mesoporous structure, biocompatibility, polymeric hybridizability, modifiability, and tunable pore size/diameter are among the remarkably intuitive properties of SNPs that are contributing to their growing potential applications, which include tumor targeting, solubility enhancement, tissue engineering, gene therapy, and diagnostic applications. Mesoporous nanoparticles (NPs) of silica come in many different forms including M41S, COK, SBA, KIT, and FDU. They are produced using a variety of techniques, such as chemical etching, sol-gel, template-assisted, and microwave-assisted. Over the past two decades, a vast amount of study has been conducted by numerous researchers. Also, a number of patents have been filed regarding the method of preparation and synthesis of NPs of mesoporous silica, and a number of clinical trials have been carried out in this field. This chapter compiles the significant advancements made in the last 20 years. Mesoporous silica nanoparticles for biomedical applications are being designed and developed, such as the possible therapy for various diseases, along with the work still needed in order to accomplish the clinical translation of these resources.

Abstract

Mesoporous silica materials came to light in the early 1990s when a new class of molecular sieves known as M41S was discovered. Greater surface area, mesoporous structure, biocompatibility, polymeric hybridizability, modifiability, and tunable pore size/diameter are among the remarkably intuitive properties of SNPs that are contributing to their growing potential applications, which include tumor targeting, solubility enhancement, tissue engineering, gene therapy, and diagnostic applications. Mesoporous nanoparticles (NPs) of silica come in many different forms including M41S, COK, SBA, KIT, and FDU. They are produced using a variety of techniques, such as chemical etching, sol-gel, template-assisted, and microwave-assisted. Over the past two decades, a vast amount of study has been conducted by numerous researchers. Also, a number of patents have been filed regarding the method of preparation and synthesis of NPs of mesoporous silica, and a number of clinical trials have been carried out in this field. This chapter compiles the significant advancements made in the last 20 years. Mesoporous silica nanoparticles for biomedical applications are being designed and developed, such as the possible therapy for various diseases, along with the work still needed in order to accomplish the clinical translation of these resources.

Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/9783111338477-009/html
Scroll to top button